| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| isavuconazole | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank | Zygomycosis[MeSHID:D020096] Mucormycosis[MeSHID:D009091] Aspergillosis[MeSHID:D001228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Candidemia[MeSHID:D058387] Systemic candidiasis[MeSHID:C536777] Invasive Candidiasis[MeSHID:D058365] |
NA | approved,investigational | inhibitor |
| isavuconazole | potassium voltage-gated channel subfamily a member 5 | small molecule | NA | drugbank | Zygomycosis[MeSHID:D020096] Mucormycosis[MeSHID:D009091] Aspergillosis[MeSHID:D001228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Candidemia[MeSHID:D058387] Systemic candidiasis[MeSHID:C536777] Invasive Candidiasis[MeSHID:D058365] |
NA | approved,investigational | inhibitor |
| isavuconazole | potassium voltage-gated channel subfamily d member 3 | small molecule | NA | drugbank | Zygomycosis[MeSHID:D020096] Mucormycosis[MeSHID:D009091] Aspergillosis[MeSHID:D001228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Candidemia[MeSHID:D058387] Systemic candidiasis[MeSHID:C536777] Invasive Candidiasis[MeSHID:D058365] |
NA | approved,investigational | inhibitor |
| isavuconazole | potassium voltage-gated channel subfamily h member 2 | small molecule | NA | drugbank | Zygomycosis[MeSHID:D020096] Mucormycosis[MeSHID:D009091] Aspergillosis[MeSHID:D001228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Candidemia[MeSHID:D058387] Systemic candidiasis[MeSHID:C536777] Invasive Candidiasis[MeSHID:D058365] |
NA | approved,investigational | inhibitor |
| isavuconazole | atp-sensitive inward rectifier potassium channel 11 | small molecule | NA | drugbank | Zygomycosis[MeSHID:D020096] Mucormycosis[MeSHID:D009091] Aspergillosis[MeSHID:D001228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Candidemia[MeSHID:D058387] Systemic candidiasis[MeSHID:C536777] Invasive Candidiasis[MeSHID:D058365] |
NA | approved,investigational | inhibitor |
| isavuconazole | g protein-activated inward rectifier potassium channel 2 | small molecule | NA | drugbank | Zygomycosis[MeSHID:D020096] Mucormycosis[MeSHID:D009091] Aspergillosis[MeSHID:D001228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Candidemia[MeSHID:D058387] Systemic candidiasis[MeSHID:C536777] Invasive Candidiasis[MeSHID:D058365] |
NA | approved,investigational | inhibitor |
| isavuconazole | g protein-activated inward rectifier potassium channel 3 | small molecule | NA | drugbank | Zygomycosis[MeSHID:D020096] Mucormycosis[MeSHID:D009091] Aspergillosis[MeSHID:D001228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Candidemia[MeSHID:D058387] Systemic candidiasis[MeSHID:C536777] Invasive Candidiasis[MeSHID:D058365] |
NA | approved,investigational | inhibitor |
| isavuconazole | potassium voltage-gated channel subfamily kqt member 1 | small molecule | NA | drugbank | Zygomycosis[MeSHID:D020096] Mucormycosis[MeSHID:D009091] Aspergillosis[MeSHID:D001228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Candidemia[MeSHID:D058387] Systemic candidiasis[MeSHID:C536777] Invasive Candidiasis[MeSHID:D058365] |
NA | approved,investigational | inhibitor |
| isavuconazole | sodium channel protein type 5 subunit alpha | small molecule | NA | drugbank | Zygomycosis[MeSHID:D020096] Mucormycosis[MeSHID:D009091] Aspergillosis[MeSHID:D001228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Candidemia[MeSHID:D058387] Systemic candidiasis[MeSHID:C536777] Invasive Candidiasis[MeSHID:D058365] |
NA | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||